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The effect of a ferriprotoporphyrin IX -chloroquine complex on phospholipid membranes was investigated 
on the basis of iron-induced lipid peroxidation using microsomal phospholipid liposomes. The ferriproto- 
porphyrin IX -chloroquine complex remarkably promoted peroxidative cleavage of unsaturated phospholi- 
pids in liposomes, compared with ferriprotoporphyrin IX alone. Neither the combination of protoporphyrin 
IX with chloroquine nor the combination of Fe 3 +-ADP with chloroquine promoted lipid peroxidation. 
DL-cc-Tocopherol completely inhibited lipid peroxidation induced by the ferriprotoporphyrin IX -chloro- 
quine complex. 
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1. INTRODUCTION 
Chloroquine (7-chloro-4-(4-dimethylamino-l- 
methylbutylamino)quinoline) has been widely used 
as one of many antimalarial drugs. However, the 
mechanism of action of chloroquine in killing 
malaria parasites has not been understood. Chou 
et al. [1] and Fitch [2] have reported that FP IX, 
a main component of the malaria pigment, pro- 
duces a co-ordination complex with chloroquine. 
On the other hand, Sugioka and Nakano [3] have 
demonstrated that the ferric ion-ADP-adriamycin 
co-ordination complex induces powerful mem- 
brane lipid peroxidation of liposomes prepared 
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from microsomal phospholipids. Moreover, Tap- 
pel [4] has reported that FP IX itself could induce 
lipid peroxidation. These findings led us to 
speculate that peroxidative cleavage of vacuolar 
membranes in malaria parasites by the FP IX- 
chloroquine complex was the reason for the an- 
timalarial action of chloroquine. 
The present work was undertaken to prove a 
possible phospholipid peroxidation by the FP IX- 
chloroquine complex, using liposomes prepared 
from rat liver microsomal phospholipids as a lipid 
source. 
2. MATERIALS AND METHODS 
2.1. Reagents and enzymes 
Chloroquine, hemin (FP IX chloride) and P IX 
were purchased from Sigma. 1 mM FP IX stock 
solution in 0.02 N NaOH was prepared as de- 
scribed by Ginsburg and Demel [5]. The FP IX- 
chloroquine complex, in a molar ratio of 2 : 1, was 
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prepared by mixing chloroquine in water with a 
FP IX stock solution. The Fe’+-ADP complex was 
prepared by the method of Sugioka and Nakano 
[3]. DL+-Tocopherol was kindly supplied by Eisai 
Co. Bovine red cell superoxide dismutase and 
bovine liver catalase were obtained from Sigma 
Chemicals. The catalase was dialyzed twice against 
3 1 of 0.01 M Na-phosphate buffer at pH 7.4, prior 
to use. 
2.2. Membrane phospholipids and incubation 
experiment 
Phospholipids were extracted from rat liver 
microsomes according to Folch et al. [6] and were 
freed from contaminants (free fatty acids, 
cholesterol and its ester) by silicic acid column 
chromatography [7]. Phospholipid liposomes were 
freshly prepared with or without a-tocopherol in 
0.1 M Tris-HCl buffer at pH 7.4 as described 
previously [8]. The incubation mixture contained 
liposomes (0.8 pmol of lipid phosphorus/ml) and 
0.1 M Tris-HCl buffer at pH 7.4 in a total volume 
of 1.9 ml (for measurement of malondialdehyde) 
and 6.0 ml (for lipid analysis). In some cases, the 
mixture contained 8.8 x IO-’ M cu-tocopherol. 
Unless otherwise noticed, the reaction was initiated 
by the addition of the FP IX (25 PM)-chloroquine 
(12.5 PM) complex. All the incubation experiments 
were carried out at 37°C with continuous 
agitation. 
2.3. Assays 
Lipid peroxides were expressed as a concentra- 
tion of malondialdehyde (thiobarbiturate-reactive 
substance) in accordance with the method of 
Ohkawa et al. [9]. Fatty acid composition was 
determined by a modification of the method 
described by May and McCay [lo] using a Shimad- 
zu gas chromatography. 
3. RESULTS 
Absorption spectra of the FP IX-chloroquine 
complex, FP IX and chloroquine are shown in 
fig. 1. The spectrum of the complex was essentially 
the same as that reported by Chou et al. [l]. 
As shown in fig.2A,B, phospholipid peroxida- 
tion induced by the FP IX-chloroquine complex 
was much stronger than that displayed by FP IX 
alone, while little or no lipid peroxidation occurred 
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Fig.1. Absorption spectra of FP IX, chloroquine and 
the FP IX-chloroquine complex in 100 mM Tris-HCl 
buffer at pH 7.4. 1, 1 x lo-’ M FP IX; 2,0.5 x lo-’ M 
chloroquine; 3, 1 x 10e5 M FP IX + 0.5 x 10e5 M 
chloroquine. 
in the presence of chloroquine alone, the combina- 
tion of P IX with chloroquine or the combination 
of Fe3+-ADP with chloroquine. Each of the 
following substances, catalase at 20pg/ml, 5 x 
lo-’ M superoxide dismutase and 50 mM sodium 
benzoate (an ‘OH scavenger), did not inhibit the 
lipid peroxidation induced by FP IX or the FP IX- 
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Fig.2. Time course of lipid peroxidation induced by the 
compound added. The reaction mixture, experimental 
conditions and assay were described in section 2. (A) The 
compounds added were: none ( q ), 12.5 gM chloroquine 
(A), 25 FM FP IX (0) and the FP IX (25 pM)- 
chloroquine (12.5 PM) complex (0). (B) The 
compounds added were: the FP IX (25 PM)-chloroquine 
(12.5 PM) complex (o), the Fe3+ (25 ,uM)-ADP 
(425 PM) complex with 12.5pM chloroquine (A) and the 
combination of 25 ,uM P IX with 12.5 pM chloroquine 
(=). 
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Table 1 
Fatty acid composition in phospholipids incubated with various components for 60 min 
Incubation systema Fatty acid composition 
(moWlO mol palmitic acid) 
16:0 18:0 18:l 18:2 20:4 22:6 
Sl Basal 100 112 41 88 128 24 
S2 Basal + 12.5 PM chloroquine 100 106 43 86 130 25 
S3 Basal + 25 pM FP IX 100 112 42 85 101 17 
S4 Basal + 25 PM FP 1X-12.5 FM chloroquine 100 113 40 78 73 11 
S5 Basal + 25 pM P IX 100 112 42 85 120 22 
S6 Basal + 25 PM P IX + 12.5 FM chloroquine 100 111 44 89 123 26 
S7 S4 + 8.8 x 10m5 M cu-tocopherol 100 109 42 89 127 22 
a The reaction mixture and incubation conditions were the same as those described in section 2
chloroquine complex (not shown), indicating no 
participation of active oxygen species, such as 02, 
HzOz and ‘OH, on the lipid peroxidation. The 
replacement of 0.1 M Tris-HCl buffer with 0.01 M 
sodium phosphate buffer halved the lipid perox- 
idation induced by the FP IX-chloroquine com- 
plex (not shown). 
To determine the direct fatty acid decomposition 
in liposomes during phospholipid peroxidation, 
fatty acid decomposition in liposomes after the 
60-min incubation with or without various com- 
ponents was analyzed and compared with each 
other (table 1). The FP IX-chloroquine complex 
caused an obvious decomposition of unsaturated 
fatty acids in liposomes, especially arachidonic 
(20: 4) and docosahexaenic (22: 6) acids, while 
FP IX alone did not. No fatty acid decomposition 
occurred in the presence of chloroquine, P IX or 
the combination of P IX with chloroquine. 
Tocopherol completely protected FP IX-chloro- 
quine-mediated fatty acid decomposition. 
4. DISCUSSION 
The importance of the iron moiety in the FP IX- 
chloroquine complex for promoting lipid perox- 
idation is supported by the following findings. (i) 
Neither the combination of P IX (iron-eliminated 
FP IX) with chloroquine nor that of Fe3+-ADP 
with chloroquine promotes lipid peroxidation. (ii) 
FP IX itself causes slight, but detectable lipid 
peroxidation. At present, we do not know the 
valency of iron in the complex, either Fe”’ or Fen, 
which initiates lipid peroxidation. Even though 
there are no reducing agents added exogenously in 
the system, the iron in the complex could be re- 
duced by some manner during incubation and then 
act as an initiator of lipid peroxidation in the 
presence of Oz. It has been reported that the 
adriamycin-Fe 3+-ADP complex converts to an ac- 
tive form, the adriamycin-ADP-Fe’+ complex, by 
intramolecular self-reduction, which evokes lipid 
peroxidation [3]. The strong inhibitory effect of LY- 
tocopherol on the FP IX-chloroquine complex- 
mediated lipid peroxidation suggests the participa- 
tion of free radicals in the peroxidative cleavage of 
liposomes. 
The peroxidative cleavage of phospholipid mem- 
branes induced by the FP IX-chloroquine complex 
might well explain the antimalarial action of 
chloroquine. That is, chloroquine, which is selec- 
tively localized within the parasite food vacuoles in 
endoerythrocytic stages [ll], forms the complex 
with FP IX, a main metabolite from hemoglobin 
in vacuoles [12], and causes the peroxidative 
cleavage of phospholipid membranes of vacuoles. 
This process will lead to abnormal changes within 
the parasites, observed previously [ 11,13,14]. 
The detailed mechanism of lipid peroxidation in- 
duced by the FP IX-chloroquine complex will be 
described elsewhere. 
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